AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 104 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $5,114,000 | -5.7% | 218,534 | +23.0% | 0.01% | 0.0% |
| Q4 2015 | $5,421,000 | -39.6% | 177,742 | -21.4% | 0.01% | -47.1% |
| Q3 2015 | $8,979,000 | -37.1% | 226,015 | +9.3% | 0.02% | -26.1% |
| Q2 2015 | $14,276,000 | +407.1% | 206,731 | +301.4% | 0.02% | +360.0% |
| Q1 2015 | $2,815,000 | +10.6% | 51,503 | -13.0% | 0.01% | +25.0% |
| Q4 2014 | $2,546,000 | +24.8% | 59,176 | -7.4% | 0.00% | 0.0% |
| Q3 2014 | $2,040,000 | +44.7% | 63,923 | +4.4% | 0.00% | +33.3% |
| Q4 2013 | $1,410,000 | +34.9% | 61,221 | +25.8% | 0.00% | +50.0% |
| Q3 2013 | $1,045,000 | -9.8% | 48,655 | -6.6% | 0.00% | 0.0% |
| Q2 2013 | $1,159,000 | – | 52,076 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
| Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
| FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
| Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
| Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
| Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
| AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |